105 million shares on issue, approx. $80 million market cap.
Essentially high risk R&D in a new kind of semiconductor. Listed in 2015 by a highly credentialed team including a senior Intel executive, this stock is rerating because it now looks like the technology will be commercialised by the Chinese, who are willing to take measured risks to leapfrog US semiconductor technology to feed their own high tech industries.
The company is quite international, French, Israeli, Asian partners and only notionally Australian due to ease of funding via the ASX.
Commercialisation with one or both Chinese partners is expected in 6 - 12 months, and may even be sooner because this is one company that actually benefits from the tech separation occurring between China and the US, although it is not wedded to any one side.
The upside here is enormous but of course not certain. A $9million capital raising at 28c is not slowing things down much. Most flippers have presumably sold by now as volume has been significant.
